Excellence in Dermatology™
Excellence in Dermatologic Surgery™
Excellence in Medical Dermatology™
Excellence in Dermatopathology™

Return to program book search

Session Information

FOC U026 - Pharma Advertising: Myths and Reality

Open admission to eligible categories, no tuition or ticket


Date: Saturday, March 22

CME Credits: 1.50

Location: Room 607

Time: 7:15 AM - 8:45 AM

Director: Jeffrey J. Meffert, MD, FAAD

Learning Objectives:
Following this course, the attendee should be able to:

  • Compare the different types of pharmaceutical advertising according to FDA standards
  • Describe the process for reporting suspected marketing violations
  • Distinguish "proper" from "improper" advertisements

The FDA scientifically evaluates all prescription and OTC drugs and devices before they can be marketed and reviews and approves all advertising for them before publication, right? Wrong. OTCs are generally approved as safe, not necessarily effective. The FDA does not pre-approve advertisements. Advertising standards exist but the FDA only hears about deceptive advertising or improper marketing when someone complains.